We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Solvay Receives Approvable Letter for Creon
Solvay Receives Approvable Letter for Creon
August 24, 2007
The FDA recently issued an approvable letter to Solvay Pharmaceuticals for its pancreatic exocrine insufficiency treatment Creon.